Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies

INTRODUCTION: Budesonide-formoterol taken as needed is an emerging treatment for mild asthma. OBJECTIVE: We used data from the SYGMA studies to assess the safety of As-needed budesonide-formoterol compared with As-needed terbutaline and compared with maintenance budesonide. METHODS: SYGMA 1 and 2 we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Saf
Autors principals: FitzGerald, J. Mark, O’Byrne, Paul M., Bateman, Eric D., Barnes, Peter J., Zheng, Jinping, Ivanov, Stefan, Lamarca, Rosa, Larsdotter, Ulrika, Emerath, Ulrika, Jansen, Gerreke, Puu, Margareta, Alagappan, Vijay K. T., Surmont, Filip, Reddel, Helen K.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2021
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7994217/
https://ncbi.nlm.nih.gov/pubmed/33548020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-020-01041-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars